DepoMedrol

PreclinicalSmall molecule

IIsfahan University of Medical Sciences

DepoMedrol is one of 34 small molecule programs targeting Lateral Epicondylitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lateral EpicondylitisActive, not recruiting

Spinal StenosisActive, not recruiting

Lateral EpicondylitisPhase 2/Phase 3

Active, not recruiting

Spinal StenosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

52 competitors in Lateral Epicondylitis

#DrugCompanyPhaseTrials

Aleve

Alnylam Pharmaceuticals

Approved

2 2

Xylocaine

MMEDRx USA, Inc.

Approved

1 3

Kenalog

BBassett Healthcare

Approved

1 4

Aspercreme Warming

AAveritas Pharma, Inc.

Approved

—5

Kenalog

BBausch Health Americas, Inc.

Approved

—6

Decadron

AAspen Global Incorporated

Approved

—7

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Rayos

Isotonic Sodium Chloride

Eli Lilly

Approved

1 10

Kenalog

MMichael Khazzam

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prospective1 trial

EuroPainClinics® Study II (Prospective Trial)

Completed·EEPC Education s.r.o.·N/A·NCT02459392·300 enrolled

Greater Trochanteric Pain Syndrome1 trial

Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome

Withdrawn·EEmory University·Phase 4·NCT00863889

Chemotherapy1 trial

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Unknown status·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT02611492·265 enrolled

Spinal Stenosis1 trial

AlloGen-LI Treatment of Spinal Stenosis

Withdrawn·UUniversity of Southern California·N/A·NCT02932020

Randomized Controlled Trial1 trial

Does Injection Site Matter? A Randomized Controlled Trial to Evaluate Efficacy of Knee Intraarticular Injections on Improval of Patient Reported Outcomes.

Completed·UUniversity of Puerto Rico·Phase 4·NCT02176304·60 enrolled

1 more indication

Lateral Epicondylitis1 trial

Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis

Completed·IIsfahan University of Medical Sciences·Phase 2/3·NCT01986465·78 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for DepoMedrol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — DepoMedrol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for DepoMedrol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Isfahan University of Medical Sciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: IIsfahan University of Medical Sciences

DepoMedrol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prospective1 trial

Greater Trochanteric Pain Syndrome1 trial

Chemotherapy1 trial

Spinal Stenosis1 trial

Randomized Controlled Trial1 trial

Lateral Epicondylitis1 trial

References

Drug Info

Quick Facts

Related News